Capitalisation Boursière Changement Date
argenx SE USD 57.63B 13.25B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Biogen USD 31.9B 5B 2026-06
Genmab DKK 17.1B 88.06B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
GRIFOLS EUR 5.41B 181.49M 2026-06
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Incyte USD 22.65B 3.92B 2026-06
Merck EUR 18.98B 27.8B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
UCB EUR 46.41B 13.94B 2025-12
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06